Follow-up Visits

INDICATION

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Continue prevention practices with DESCOVY FOR PrEP1,2

Screen patients for HIV every 3 months and upon diagnosis of an STI

Here's a brief overview of what you need to do during follow-up visits:

DESCOVY® Co-pay Support

CDC=Centers for Disease Control and Prevention; STI=sexually transmitted infection.